Physician profile
Patrick Brown
NPI 1679181747
$3,151.18
in general payments reported to CMS, 2019-2025
18 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $546 · 2023: $782 · 2024: $536 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,346 · Entertainment: $62.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,346.25 |
| Entertainment | $62.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $512.51 | 2021-2023 | Hydrus Microstent |
| Bausch & Lomb Americas INC. | $498.62 | 2023-2024 | Infuse, Toric, Stellaris |
| Abbvie INC. | $455.92 | 2022-2025 | Lumigan, Vuity, Alphagan P |
| New World Medical,INC. | $388.94 | 2024-2025 | Streamline, Ahmed Glaucoma Valve, Clearpath |
| Johnson & Johnson Surgical Vision, INC. | $264.87 | 2022-2023 | Lipiflow System Activator (Disposable) |
| Amgen INC. | $163.01 | 2025 | Tepezza |
| Coopervision INC. | $150.96 | 2024-2025 | Myday Contact Lens |
| Harrow Eye, LLC | $129.71 | 2025 | Vevye |
| Mallinckrodt Hospital Products INC. | $120.37 | 2025 | Acthar |
| Topcon Healthcare, INC. | $79.26 | 2022 | |
| Optos, INC. | $62.32 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Astellas Pharma US INC | $60.94 | 2024-2025 | Izervay |
| Dompe US, INC. | $51.86 | 2022-2024 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $51.47 | 2024-2025 | Xdemvy |
| Apellis Pharmaceuticals, INC. | $43.24 | 2024-2025 | Syfovre |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $40.60 | 2022-2023 | Tyrvaya |
| Rxsight INC | $38.46 | 2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Sun Pharmaceutical Industries INC. | $38.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.